Published in ACS Nano on September 12, 2013
Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc Natl Acad Sci U S A (2014) 1.20
Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. ACS Nano (2014) 0.93
Glucose oxidase-catalyzed growth of gold nanoparticles enables quantitative detection of attomolar cancer biomarkers. Anal Chem (2014) 0.92
Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers. J Am Chem Soc (2014) 0.91
Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group. JACC Basic Transl Sci (2016) 0.83
Aptamer-based sandwich-type biosensors. J Biol Eng (2017) 0.81
Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology. Trends Biotechnol (2014) 0.78
Mathematical framework for activity-based cancer biomarkers. Proc Natl Acad Sci U S A (2015) 0.77
Smart nanosystems: Bio-inspired technologies that interact with the host environment. Proc Natl Acad Sci U S A (2015) 0.76
Research Highlights: highlights from the latest articles in nanomedicine. Nanomedicine (Lond) (2014) 0.75
Therapeutic benefits of nanoparticles in stroke. Front Neurosci (2015) 0.75
Thrombosis: Novel nanomedical concepts of diagnosis and treatment. World J Cardiol (2015) 0.75
Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling. Nano Lett (2016) 0.75
The melding of nanomedicine in thrombosis imaging and treatment: a review. Future Sci OA (2016) 0.75
A synthetic urinary probe-coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis. Int J Nanomedicine (2017) 0.75
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol (2003) 10.76
Nanostructures in biodiagnostics. Chem Rev (2005) 9.96
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
Creatine and creatinine metabolism. Physiol Rev (2000) 5.76
Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem (2010) 4.88
An immunological pregnancy test. Acta Endocrinol (Copenh) (1960) 4.18
Point-of-care diagnostics for global health. Annu Rev Biomed Eng (2008) 4.11
The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol (2006) 3.79
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol (2009) 3.55
Triggers, targets and treatments for thrombosis. Nature (2008) 3.51
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol (2003) 3.06
Discovery of urinary biomarkers. Mol Cell Proteomics (2006) 2.70
Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta (2004) 2.61
Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol (2000) 2.49
Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res (1998) 2.33
Biomarkers in chronic kidney disease: a review. Kidney Int (2011) 2.25
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Urinary proteomics in diabetes and CKD. J Am Soc Nephrol (2008) 2.12
Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost (1994) 2.10
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol (2002) 2.06
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol (2002) 1.87
A photometric method for the determination of insulin in plasma and urine. J Biol Chem (1949) 1.84
Protection against thrombosis in mice lacking PAR3. Blood (2002) 1.74
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist. J Thromb Haemost (2003) 1.72
Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ (2007) 1.69
Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc Imaging (2012) 1.66
Molecular recognition mechanisms of thrombin. J Thromb Haemost (2005) 1.66
Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens (2003) 1.58
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation (2004) 1.53
Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms. Blood (2001) 1.47
An overview of the structure and function of thrombin. Semin Thromb Hemost (2006) 1.43
Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology (2009) 1.34
Constancy of urinary creatinine excretion. J Lab Clin Med (1958) 1.29
Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care (2003) 1.27
Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology (2000) 1.26
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med (1998) 1.24
Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc Natl Acad Sci U S A (2014) 1.20
Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliv Rev (2012) 1.11
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb) (2012) 1.11
Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology (2000) 1.11
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol (2012) 1.10
Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia (1999) 1.10
Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective. Nephrology (Carlton) (2010) 1.07
Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238). Thromb Res (1978) 1.03
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol (2006) 1.03
Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation. Angew Chem Int Ed Engl (2012) 1.00
Measurement of glomerular filtration rate. Kidney Int Suppl (1997) 0.99
A novel near-infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem (2002) 0.94
Thrombin: Structure, Biochemistry, Measurement, and Status in Clinical Medicine. J Thromb Thrombolysis (1998) 0.84
Urine and plasma levels of fibrinopeptide B in patients with deep vein thrombosis and pulmonary embolism. Thromb Res (2003) 0.80
Design and synthesis of thrombin substrates with modified kinetic parameters. Thromb Res (1995) 0.79
Protease sensing with nanoparticle based platforms. Analyst (2010) 0.77
Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancy. J Clin Endocrinol Metab (1994) 0.77
Assay for plasma heparin using a synthetic peptide substrate for thrombin: introduction of the fluorophore aminoisophthalic acid, dimethyl ester. Thromb Res (1978) 0.77
A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915). Clin Chim Acta (1984) 0.76
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol (2008) 4.40
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A (2007) 3.53
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods (2006) 3.20
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J (2006) 2.95
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med (2011) 2.54
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins. J Am Chem Soc (2007) 2.42
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Cancer vulnerabilities unveiled by genomic loss. Cell (2012) 1.95
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Synergistic effects of combining morphological and molecular data in resolving the phylogeny of butterflies and skippers. Proc Biol Sci (2005) 1.90
Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones. Nat Mater (2004) 1.89
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Microfabricated platform for studying stem cell fates. Biotechnol Bioeng (2004) 1.77
Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev (2008) 1.76
Three-dimensional tissue fabrication. Adv Drug Deliv Rev (2004) 1.76
Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science (2003) 1.72
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano (2012) 1.58
Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng (2003) 1.58
Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng (2003) 1.58
Positive selection of a duplicated UV-sensitive visual pigment coincides with wing pigment evolution in Heliconius butterflies. Proc Natl Acad Sci U S A (2010) 1.57
The life history and shelter building behavior of Vettius coryna coryna Hewitson, 1866 in eastern Ecuador (Lepidoptera: Hesperiidae: Hesperiinae). J Insect Sci (2009) 1.55
Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci U S A (2010) 1.53
Engineering protein and cell adhesivity using PEO-terminated triblock polymers. J Biomed Mater Res (2002) 1.50
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49
A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun (2012) 1.47
Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip (2004) 1.46
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed Engl (2006) 1.39
Tissue-specific gene delivery via nanoparticle coating. Biomaterials (2009) 1.34
Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology (2009) 1.33
Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng (2004) 1.32
A biophysical indicator of vaso-occlusive risk in sickle cell disease. Sci Transl Med (2012) 1.32
Protease-triggered unveiling of bioactive nanoparticles. Small (2008) 1.30
Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res (2005) 1.26
Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater (2010) 1.26
Local heating of discrete droplets using magnetic porous silicon-based photonic crystals. J Am Chem Soc (2006) 1.25
In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci (2004) 1.24
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells. Proc Natl Acad Sci U S A (2010) 1.20
Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc Natl Acad Sci U S A (2014) 1.20
Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling. Hepatology (2004) 1.20
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci U S A (2013) 1.19
Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew Chem Int Ed Engl (2010) 1.18
Assessment of hepatocellular function within PEG hydrogels. Biomaterials (2006) 1.18
HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol (2006) 1.17
Mitochondrial localization and the persistent migration of epithelial cancer cells. Biophys J (2013) 1.16
High-throughput analysis of signals regulating stem cell fate and function. Curr Opin Chem Biol (2007) 1.15
Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc (2011) 1.15
Engineering tissues for in vitro applications. Curr Opin Biotechnol (2006) 1.15
Multiphase electropatterning of cells and biomaterials. Lab Chip (2007) 1.13
Effect of nanoparticle conjugation on gene silencing by RNA interference. J Am Chem Soc (2010) 1.11
Nanoparticle self-assembly gated by logical proteolytic triggers. J Am Chem Soc (2007) 1.11
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol (2012) 1.10
Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1. J Am Chem Soc (2011) 1.08
Microscale control of cell contact and spacing via three-component surface patterning. Langmuir (2007) 1.06
Timing major conflict between mitochondrial and nuclear genes in species relationships of Polygonia butterflies (Nymphalidae: Nymphalini). BMC Evol Biol (2009) 1.05
The smart Petri dish: a nanostructured photonic crystal for real-time monitoring of living cells. Langmuir (2006) 1.05
The pipeline still leaks and more than you think: a status report on gender diversity in biomedical engineering. Ann Biomed Eng (2010) 1.02
High-density, multiplexed patterning of cells at single-cell resolution for tissue engineering and other applications. Angew Chem Int Ed Engl (2011) 1.01
Engineering liver therapies for the future. Tissue Eng (2002) 1.01
Laminin and fibronectin modulate inner ear spiral ganglion neurite outgrowth in an in vitro alternate choice assay. Dev Neurobiol (2007) 0.99
Multiplexed, high-throughput analysis of 3D microtissue suspensions. Integr Biol (Camb) (2010) 0.99
The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials (2008) 0.99
Statistical dynamics of flowing red blood cells by morphological image processing. PLoS Comput Biol (2009) 0.99
Modulation of hepatocyte phenotype in vitro via chemomechanical tuning of polyelectrolyte multilayers. Biomaterials (2008) 0.97
Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors. Cell Cycle (2013) 0.97
Geometric and material determinants of patterning efficiency by dielectrophoresis. Biophys J (2004) 0.96
Silicon nanoparticles as hyperpolarized magnetic resonance imaging agents. ACS Nano (2009) 0.95
Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng Part A (2014) 0.95
Fabrication of three-dimensional tissues. Adv Biochem Eng Biotechnol (2007) 0.94
Genetic Circuits in Salmonella typhimurium. ACS Synth Biol (2012) 0.93
DNA-templated assembly of droplet-derived PEG microtissues. Lab Chip (2011) 0.93
Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. ACS Nano (2014) 0.93
Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41. FEBS J (2007) 0.91